Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes after Transcatheter Aortic Valve Implantation

Yigal Abramowitz, Tarun Chakravarty, Hasan Jilaihawi, Chin Lee, Justin Cox, Rahul P. Sharma, Geeteshwar Mangat, Wen Cheng, Raj R. Makkar

Research output: Contribution to journalArticlepeer-review

23 Scopus citations


There are limited data on the effect of baseline B-type natriuretic peptide (BNP) on the outcome after transcatheter aortic valve implantation (TAVI). We investigated the influence of baseline BNP levels on the short-term and midterm clinical outcomes after TAVI. During a 3-year period, 780 patients with severe aortic stenosis underwent TAVI at our institute and had baseline BNP levels. We compared the high, mid, and low tertiles of BNP levels. TAVI end points, device success, and adverse events were considered according to the Valve Academic Research Consortium 2 definitions. Device success was significantly lower for patients with high BNP (98.1% vs 96.2% vs 91.9% for the low, mid, and high BNP tertiles, respectively; p = 0.003). All-cause mortality up to 30 days was 1.2% (3 of 260) versus 2.3% (6 of 260) versus 5% (13 of 260), respectively (p = 0.03). Six-month mortality rate was 4.1% (10 of 241) for the low BNP tertile, 5% (12 of 239) for the mid BNP tertile, and 17.1% (40 of 234) for the high BNP tertile (p <0.001). In the multivariate model, high tertile of baseline BNP was found to be significantly associated with all-cause mortality (hazard ratio 3.3, 95% confidence interval 1.64 to 6.48; p = 0.001). In conclusion, elevated BNP levels are associated with increased short-term and midterm mortality after TAVI. We recommend measurement of baseline BNP as part of risk stratification models for TAVI.

Original languageEnglish
Pages (from-to)1904-1909
Number of pages6
JournalAmerican Journal of Cardiology
Issue number12
StatePublished - 15 Dec 2015
Externally publishedYes

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes after Transcatheter Aortic Valve Implantation'. Together they form a unique fingerprint.

Cite this